Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Cerilliant
Deloitte
Merck
Dow
Colorcon
Boehringer Ingelheim
McKinsey
Mallinckrodt

Generated: April 26, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,730,288

« Back to Dashboard

Summary for Patent: 6,730,288
Title: Mousse composition
Abstract:A pharmaceutical aerosol foam composition including an effective amount of a pharmaceutically active ingredient; an occlusive agent; an aqueous solvent; and an organic cosolvent, the pharmaceutically active ingredient being insoluble in both water and the occlusive agent; the occlusive agent being present in an amount sufficient to form an occlusive layer on the skin, in use.
Inventor(s): Abram; Albert Zorko (Wantirna, AU)
Assignee: Connetics Australia Pty Ltd (Rowville, AU)
Application Number:09/719,662
Patent Claim Types:
see list of patent claims
Composition; Delivery;

Drugs Protected by US Patent 6,730,288

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Bayer Hlthcare FINACEA azelaic acid AEROSOL, FOAM;TOPICAL 207071-001 Jul 29, 2015 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Mylan Pharms Inc OLUX E clobetasol propionate AEROSOL, FOAM;TOPICAL 022013-001 Jan 12, 2007 AB2 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Aqua Pharms VERDESO desonide AEROSOL, FOAM;TOPICAL 021978-001 Sep 19, 2006 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,730,288

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
AustraliaPP5831Sep 11, 1998
PCT Information
PCT FiledSeptember 08, 1999PCT Application Number:PCT/AU99/00735
PCT Publication Date:March 23, 2000PCT Publication Number: WO00/15193

Non-Orange Book US Patents Family Members for Patent 6,730,288

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,298,515 Vitamin formulation ➤ Sign Up
8,629,128 Vitamin formulation ➤ Sign Up
7,029,659 Mousse composition ➤ Sign Up
8,263,580 Vitamin formulation ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
McKinsey
Daiichi Sankyo
US Army
Boehringer Ingelheim
Cipla
Cantor Fitzgerald
Accenture
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.